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Abstract  
Hyponatraemia often poses a diagnostic 
dilemma, brought about by inadequate work-up and 
inappropriate management. In order to make the 
correct diagnosis, an understanding of the 
pathophysiology and classification of 
hyponatraemia is essential. In this review, focus is 
made on the diagnosis of pseudohyponatraemia 
including the causes, when to suspect it and how to 
diagnose it. Different analytical methods are 
discussed, including flame emission 
spectrophotometry, and ion-specific electrode (ISE) 
potentiometry and the role they play in diagnosing 
pseudohypopatraemia. The measured and calculated 
osmolalities and their use to calculate the osmolal 
gap are explained. Finally, a discussion follows on 
the aetiologies of pseudohyponatraemia, strategies 
to circumvent this problem and the relevance of 
clinching the diagnosis in clinical practice. 
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Measurement of serum sodium concentration 
is amongst the most commonly requested tests in 
clinical practice. A diagnosis of hyponatraemia is 
made in up to 2% to 3% of hospitalised patients.1 
However, it is frequently overlooked, misdiagnosed 
and mismanaged. Measurement of serum osmolality 
and assessment of fluid status are the crux to 
distinguishing between the different causes of 
hyponatraemia, while giving due consideration to 
the possibility of a spuriously low serum sodium 
level – pseudohyponatraemia (figure 1). 
For around thirty years, flame emission 
spectrophotometry (FES) was the technique of 
choice for measuring the major cations, sodium and 
potassium. Although still in use as a reference 
method, in the 1980s FES was replaced across most 
laboratories by ion-specific electrode (ISE) 
potentiometry. The latter measures the potential 
difference across a reference electrode and a 
measuring electrode being exposed to the selected 
ion (in this case sodium). Two ISE techniques are 
available for measurement of plasma sodium 
concentration – direct and indirect ISE 
potentiometry. With direct ISE potentiometry, the 
sample is presented to the measuring electrode 
undiluted, whereas indirect ISE potentiometry 
requires that the sample is first diluted in a buffer.3 
Of the two techniques, indirect ISE is the more 
widely used, as diluting the sample allows for the 
serum sodium ionic activity, measured in milliVolts 
(mV), to be used as a close approximation of the 
serum sodium concentration. Only atoms that 
undergo ionisation are activated, and this ionisation 
takes place via a pre-analytical dilution of 1:10.4 
This method is used in over two-thirds of 
laboratories across the United States and likewise 
affects the measurement of other similarly 
measured ions including potassium, chloride and 
calcium.5 However, since the concentration of 
sodium is far greater than that of the other ions, the 
analytical error is also greater. On the other hand, 
point-of-care machine analysers (such as blood-gas 
analysers) use direct ISE and measure the sodium 
activity without requiring a dilution step, hence 
allowing for direct measurement of the sodium 
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concentration in plasma water.  
  In the healthy subject, water constitutes 93% 
of plasma volume, whilst the remaining 7% consists 
of undissolved particles, mostly lipids and proteins.6 
All plasma electrolytes are confined to the aqueous 
phase and hence it is the concentration of sodium in 
the aqueous phase that is physiologically relevant. 
In patients with severe hyperlipidaemia or 
hyperproteinaemia, the increased amounts of 
protein or lipid in the non-aqueous phase will 
occupy more than 7% of the total plasma volume 
and will hence alter the 93:7 aqueous to non-
aqueous ratio. This ratio of 93:7 is the basis for 
measuring serum sodium concentration using 
indirect ion-specific electrode (ISE) potentiometry. 
If the non-aqueous phase increases at the expense of 
the aqueous phase, then the serum sodium can no 
longer be predicted from the total plasma volume 
(aqueous plus non-aqueous) using this ratio.  In 
patients with pseudohyponatraemia the sodium 
concentration in aqueous phase of plasma is normal, 
however indirect ISE potentiometry measures the 
serum sodium in the total plasma volume, without 
taking into account instances when the aqueous 
phase occupies less volume than usual (figure 2).7 
 
 
Figure 1 
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The easiest method to diagnose 
pseudohyponatraemia is by measuring serum 
sodium concentration using a direct ISE 
potentiometer (such as a blood gas analyser).8  If 
this is not available, plasma triglyceride and total 
protein concentration can be used to calculate the 
percentage water content of serum, with a value less 
than 93% being in keeping with a possible 
diagnosis of pseudohyponatraemia.9 The first step 
in calculating the serum sodium concentration 
requires the percentage of serum water, obtained 
using the following equation:10 
 
Serum water (%) = 99.1- (1.1 x 10-5 x [triglyceride 
in mmol/L]) - (0.07x [protein in g/L]) 
 
The corrected sodium concentration is then 
calculated by multiplying the laboratory (indirect) 
serum sodium by 93% (i.e the normal serum water 
percentage) and dividing it by the calculated serum 
water % (calculated using the above equation). The 
second step allows for the adjustment of the 
calculated serum sodium to a normal serum water 
percentage (figure 3).   
 
Figure 3 
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Pseudohyponatraemia should be suspected in 
the following circumstances: 
• There is a significant discrepancy between the
measured osmolality (which is normal in
pseudohyponatraemia) and the calculated
osmlolality i.e. the presence of a raised
osmolal gap, defined as the difference
between the measured osmlolality and the
calculated osmolality (the calculated
osmolality being lower than the measured
osmolality in cases of pseudohyponatraemia).
The measured serum osmolality remains
unperturbed by changes in the ratio of the
plasma constituents, as only the solutes which
dissolve in the aqueous phase contribute to its
measurement.11
• The serum sodium does not correlate with the
clinical signs.12
• Hyponatraemia in a patient suffering from
uncontrolled diabetes mellitus.  Of note, the
pseudohyponatraemia in this case is secondary
to an associated hyperlipidaemia and should
be differentiated from hyponatraemia caused
by hyperglycaemia. In the latter case, glucose
acts as an active osmole causing water to
move from the intravascular to the
extravascular space and hence resulting in a
true, dilutional hyponatraemia secondary to an
osmotic diuresis. As a rule of thumb, an
increase of plasma glucose of 5 mmol/L
results in a decrease in plasma sodium of 1.6-
2.4 mmol/L.13
• The specimen is grossly lipaemic. For every
12 mmol/L increase in serum triglyceride
levels, serum sodium decreases by
approximately 1.5 mmol/L.14
• In patients known to suffer from a
paraproteinaemia or being treated with
intravenous immunoglobin (IVIg). In this case
each gram of monoclonal protein decreases
serum sodium by 0.7 mmol/L.15
Interestingly the phenomenon of 
pseudohypernatraemia can conversely arise in 
patients suffering from hypoproteinaemia.5 Also of 
note is that hypertriglyceridaemia is far more likely 
to cause pseudohyponatraemia than 
hypercholesterolaemia – this is because 
triglycerides have a 2.5-fold greater molecular 
weight (C57H10406 = 885.4 g/mol) compared to 
cholesterol (C27H460 = 386.7 g/mol) which results 
in lack of visible turbidity when 
hypercholesterolaemia is the culprit.5,15,16 
Nevertheless, although uncommon, 
hypercholesterolaemia has been described as a 
cause of pseudohyponatraemia in the context of 
obstructive jaundice and elevated levels of 
lipoprotein X.17-22 Extreme hypertriglyceridaemia, 
in excess of 10 mmol/L, results in an increase in the 
non-aqueous phase of plasma and contraction of the 
aqueous phase. Clinical manifestations may include 
lipaemia retinalis and eruptive xanthomata and 
unfortunately acute pancreatitis remains a very 
serious complication. It may result from a gene 
defect involving the activity of lipoprotein lipase 
(directly or indirectly) or may more commonly be 
precipitated by conditions such as poorly controlled 
diabetes, obesity, excessive alcohol consumption, 
hypothyroidism and lipodystrophy.23 
Conclusion 
Pseudohyponatraemia is an artefactual reading 
occurring when the measured serum sodium is 
normal, but the calculated serum sodium is 
erroneously low, hence resulting in an increased 
osmolal gap.11 The condition only arises in cases of 
severe hypertriglyceridemia and hyperproteinaemia 
(most commonly multiple myeloma24), when serum 
sodium is measured using indirect ISE 
potentiometry or FES, both of which involve 
predilution of the blood samples. The exclusion of 
sodium from the non-aqueous phase is the basis for 
understanding why predilution photometry can 
result in pseudohyponatraemia if the plasma volume 
occupied by the aqueous phase changes. As the 
lipid concentration increases, the water content in 
plasma decreases, and hence, the larger the error of 
pseudohyponatraemia. Whilst it is rare for serum 
triglycerides or proteins to rise to such high levels 
as to result in pseudohyponatraemia, it is of 
paramount importance that this artefact is 
recognised and not treated as true hyponatraemia. 
When in doubt, serum sodium should be measured 
using direct ISE potentiometry, as failure to 
recognise pseudohyponatraemia may lead to 
inappropriate choice of treatment and death from 
hypernatraemia.25-26 
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